DRAM vs SOXX: Which Is the Better Pick in 2026?

Overview

DRAM and SOXX are both technology-focused equity ETFs, but they target fundamentally different segments. SOXX is a broad semiconductor index fund tracking 30+ US-listed chipmakers across the full spectrum—logic, memory, equipment, and analog. DRAM is a narrower thematic fund concentrating on memory-chip manufacturers and AI-adjacent semiconductor subsectors. The key distinction: SOXX provides diversified sector exposure; DRAM bets on a specific memory-and-AI narrative within semiconductors.

How they differ

SOXX tracks an established broad index (ICE Semiconductor Index) with 30+ holdings dating to 2001, while DRAM is a newer thematic play launched in 2026 focused explicitly on memory and AI. SOXX pays a 0.18% distribution yield quarterly; DRAM pays no distributions. The most significant structural difference is beta: SOXX has a beta of 2.26, meaning it swings roughly twice as hard as the broad market, while DRAM's beta of 0.0 signals either a very new fund with insufficient historical data or a hedge-adjusted strategy. SOXX is substantially larger ($36.9B in AUM versus $17.5B) and cheaper to own at a 0.35% expense ratio versus DRAM's 0.65%.

Who each is best for

SOXX: Fits investors seeking broad semiconductor sector exposure through an index-based vehicle with decades of track record, who can tolerate high market-sensitive volatility and are comfortable with a lower yield in exchange for diversification across logic, memory, and equipment subsectors.

DRAM: Designed for investors with a conviction view on memory-chip demand and AI infrastructure, who prioritize thematic concentration over diversification, have a longer time horizon (given the growth-oriented, non-income structure), and can accept a newer fund with limited operating history.

Key risks to know

• Index concentration versus thematic concentration: SOXX holds 30+ positions across semiconductor value chains, reducing single-company risk; DRAM's memory-and-AI focus concentrates capital in fewer names, amplifying the impact of competitive shifts in memory pricing or AI-chip adoption cycles.

• Cyclical semiconductor earnings sensitivity: Both funds are exposed to chip-cycle volatility—capacity gluts, pricing pressure, and inventory corrections can drive sharp earnings revisions. SOXX's higher beta (2.26) amplifies downside during demand slowdowns; DRAM's growth orientation and thematic positioning may amplify drawdowns if memory or AI infrastructure cycles weaken.

• DRAM beta and data maturity: The reported 0.0 beta for DRAM, combined with its April 2026 inception, suggests either very limited historical data or a beta calculation artifact. This makes it difficult to assess how the fund will correlate with market stress or rate shocks in a full market cycle.

• Geopolitical and regulatory risk: Semiconductor supply chains face China-related export controls and ongoing US trade policy uncertainty. Both funds carry this risk, but DRAM's narrower focus on memory and AI may face heightened scrutiny if memory-chip exports become restricted.

Bottom line

SOXX offers a proven, diversified entry to semiconductors with lower costs and a 25-year operating history, though its 2.26 beta means larger swings. DRAM targets a narrower memory-and-AI thesis with growth ambitions but limited track record and higher fees, making it a bet on a specific subsector narrative rather than broad chip-sector health. If you value simplicity and diversification with an established fund, SOXX stands out; if you have conviction about memory-chip and AI-infrastructure demand and can accept concentration risk, DRAM's focused approach may appeal. Past performance does not predict future results.